AIXIAL GROUP
Sara Villeneuve is a seasoned pharmaco-epidemiologist currently working at AIXIAL since July 2021, with previous roles as an epidemiologist and biostatistician at CPias Ile-de-France and IQVIA. Sara's extensive experience includes significant contributions to epidemiological studies on occupational exposure and health outcomes, particularly in cancer, rheumatoid arthritis, and chronic conditions. Educational qualifications include a PhD in Epidemiology from the Faculté de médecine du Kremlin Bicêtre, supplemented by multiple advanced degrees in biostatistics, bioinformatics, and mathematics. Throughout a career spanning over a decade, Sara has engaged in various research projects, including the development of exposure matrices and patient registries, showcasing a strong foundation in statistical analysis and epidemiological methods.
This person is not in any teams
This person is not in any offices
AIXIAL GROUP
2 followers
Bringing reliability and expertise to clinical development. Aixial Group is a specialized clinical development partner with the commitment, expertise, and flexibility needed to deliver efficient clinical trials. Aixial Group provides the industry with an innovative and scalable offering, which includes: comprehensive clinical trial design and execution; functional service delivery; resources and platform. For more information, please visit: aixialgroup.com Service Delivery Models: • End to End Clinical Trial Services • Functional Service Provider (FSP) Model • Business Process Outsourcing (BPO) Model • Expert Consulting & Advice • Resourcing & Staffing